These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 8282140)
1. The effect of estriol on the cytology of urethra and vagina in postmenopausal women with genito-urinary symptoms. van der Linden MC; Gerretsen G; Brandhorst MS; Ooms EC; Kremer CM; Doesburg WH Eur J Obstet Gynecol Reprod Biol; 1993 Sep; 51(1):29-33. PubMed ID: 8282140 [TBL] [Abstract][Full Text] [Related]
2. [Usefulness of urethrocytologic studies in urinary incontinence]. Fischer W; Hannig I Zentralbl Gynakol; 1985; 107(7):424-31. PubMed ID: 4039871 [TBL] [Abstract][Full Text] [Related]
3. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Henriksson L; Stjernquist M; Boquist L; Alander U; Selinus I Am J Obstet Gynecol; 1994 Sep; 171(3):624-32. PubMed ID: 8092207 [TBL] [Abstract][Full Text] [Related]
4. Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women. Iosif CS Arch Gynecol Obstet; 1992; 251(3):115-20. PubMed ID: 1605675 [TBL] [Abstract][Full Text] [Related]
5. Low-dose, vaginally administered estrogens may enhance local benefits of systemic therapy in the treatment of urogenital atrophy in postmenopausal women on hormone therapy. Palacios S; Castelo-Branco C; Cancelo MJ; Vázquez F Maturitas; 2005 Feb; 50(2):98-104. PubMed ID: 15653006 [TBL] [Abstract][Full Text] [Related]
6. Effects of vaginally-administered oestriol on post-menopausal urogenital disorders: a cytohormonal study. Heimer GM; Englund DE Maturitas; 1992 Mar; 14(3):171-9. PubMed ID: 1508058 [TBL] [Abstract][Full Text] [Related]
7. Randomized, double-blind, placebo-controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Cruz VL; Steiner ML; Pompei LM; Strufaldi R; Fonseca FLA; Santiago LHS; Wajsfeld T; Fernandes CE Menopause; 2018 Jan; 25(1):21-28. PubMed ID: 28763401 [TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose intravaginal estriol on urogenital aging in postmenopausal women. Dessole S; Rubattu G; Ambrosini G; Gallo O; Capobianco G; Cherchi PL; Marci R; Cosmi E Menopause; 2004; 11(1):49-56. PubMed ID: 14716182 [TBL] [Abstract][Full Text] [Related]
9. The therapeutic effect of a new ultra low concentration estriol gel formulation (0.005% estriol vaginal gel) on symptoms and signs of postmenopausal vaginal atrophy: results from a pivotal phase III study. Cano A; Estévez J; Usandizaga R; Gallo JL; Guinot M; Delgado JL; Castellanos E; Moral E; Nieto C; del Prado JM; Ferrer J Menopause; 2012 Oct; 19(10):1130-9. PubMed ID: 22914208 [TBL] [Abstract][Full Text] [Related]
10. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence. Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611 [TBL] [Abstract][Full Text] [Related]
11. Urinary incontinence and related urogenital symptoms in elderly women. Molander U Acta Obstet Gynecol Scand Suppl; 1993; 158():1-22. PubMed ID: 8396841 [TBL] [Abstract][Full Text] [Related]
12. Effect of long-acting oestriol on the vaginal cytology of postmenopausal women. Purola E; Vartiainen E Ann Chir Gynaecol; 1977; 66(4):216-8. PubMed ID: 907314 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL Menopause; 2009; 16(5):978-83. PubMed ID: 19390463 [TBL] [Abstract][Full Text] [Related]
14. Continuous low dose estradiol released from a vaginal ring versus estriol vaginal cream for urogenital atrophy. Barentsen R; van de Weijer PH; Schram JH Eur J Obstet Gynecol Reprod Biol; 1997 Jan; 71(1):73-80. PubMed ID: 9031963 [TBL] [Abstract][Full Text] [Related]
15. [Is there a correlation between the degree of proliferation of vaginal and urethral epithelium and the incidence of stress incontinence? A contribution to estrogen therapy in stress incontinence]. Schwenzer T; Buth C; Degen W; Jahn K Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):158-64. PubMed ID: 3582922 [TBL] [Abstract][Full Text] [Related]
16. Ultra-low-dose estriol and lactobacilli in the local treatment of postmenopausal vaginal atrophy. Jaisamrarn U; Triratanachat S; Chaikittisilpa S; Grob P; Prasauskas V; Taechakraichana N Climacteric; 2013 Jun; 16(3):347-55. PubMed ID: 23347400 [TBL] [Abstract][Full Text] [Related]
17. [Postmenopausal vaginal atrophy and topical therapy with an estriol-based ointment (Colpogyn): authors' experience]. Oliva FA; Saltarelli E; D'Antonio GD; Mazzatenta E Minerva Ginecol; 1991 Dec; 43(12):605-7. PubMed ID: 1819780 [TBL] [Abstract][Full Text] [Related]
18. Effects of intravaginal estriol and pelvic floor rehabilitation on urogenital aging in postmenopausal women. Capobianco G; Donolo E; Borghero G; Dessole F; Cherchi PL; Dessole S Arch Gynecol Obstet; 2012 Feb; 285(2):397-403. PubMed ID: 21706345 [TBL] [Abstract][Full Text] [Related]
19. Low dose estriol pessaries for the treatment of vaginal atrophy: a double-blind placebo-controlled trial investigating the efficacy of pessaries containing 0.2mg and 0.03mg estriol. Griesser H; Skonietzki S; Fischer T; Fielder K; Suesskind M Maturitas; 2012 Apr; 71(4):360-8. PubMed ID: 22285095 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of vaginal use of topical estriol in postmenopausal women with urogenital atrophy. Chuery AC; Speck NM; de Moura KF; Belfort PN; Sakano C; Ribalta JC Clin Exp Obstet Gynecol; 2011; 38(2):143-5. PubMed ID: 21793275 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]